Imricor Medical Systems Stock Last Dividend Paid
IMR Stock | 1.16 0.06 5.45% |
Imricor Medical Systems fundamentals help investors to digest information that contributes to Imricor Medical's financial success or failures. It also enables traders to predict the movement of Imricor Stock. The fundamental analysis module provides a way to measure Imricor Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imricor Medical stock.
Imricor | Last Dividend Paid |
Imricor Medical Systems Company Last Dividend Paid Analysis
Imricor Medical's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, Imricor Medical Systems has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
All Next | Launch Module |
Imricor Fundamentals
Return On Equity | -2.75 | ||||
Return On Asset | -1.25 | ||||
Operating Margin | (19.77) % | ||||
Current Valuation | 328.6 M | ||||
Shares Outstanding | 270.18 M | ||||
Shares Owned By Insiders | 20.26 % | ||||
Shares Owned By Institutions | 14.56 % | ||||
Price To Book | 3.97 X | ||||
Price To Sales | 380.20 X | ||||
Revenue | 615.57 K | ||||
Gross Profit | (1.53 M) | ||||
EBITDA | (21.87 M) | ||||
Net Income | (34.09 M) | ||||
Total Debt | 10.42 M | ||||
Book Value Per Share | (0.03) X | ||||
Cash Flow From Operations | (19.55 M) | ||||
Earnings Per Share | (0.17) X | ||||
Target Price | 0.71 | ||||
Beta | 0.25 | ||||
Market Capitalization | 313.4 M | ||||
Total Asset | 8.31 M | ||||
Retained Earnings | (165 M) | ||||
Working Capital | (628.21 K) | ||||
Net Asset | 8.31 M |
About Imricor Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imricor Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imricor Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imricor Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imricor Stock Analysis
When running Imricor Medical's price analysis, check to measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.